Alison Nicole Petty, NP
Nurse Practitioner · Calhoun
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 12 years
- Graduated 2014
Offices
1 location · Adventist Health System Georgia Inc · 247 clinicians in this group
Hospitals listed: Adventhealth Gordon. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Alison Nicole Petty’s office at (706) 879-5770 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventhealth GordonCalhoun, GAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of AdventHealth, which runs 42 hospitals in 9 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.362, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventhealth Gordon
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 4 the same, 1 worse of 5 measures. Readmissions: 2 better, 6 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.362 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0 to 2.02) · 262 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.55 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.02 (102.68 to 227.36) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.2 · 42 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 205 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 205 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 18.3 · 89 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,214 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,837 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,779 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (1.39 to 6.23) · 315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 53 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.53 to 3.92) · 281 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.09 (1.43 to 20.76) · 60 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (1.7 to 10.22) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.21) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.863 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.106 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 75 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 422 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -15.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.7 · 216 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 354 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (3.6 to 8.5) · 57 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.1 (8.4 to 16.7) · 57 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.4 to 18.6) · 470 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 12% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 83% |
| Doctors "always" treated them with courtesy and respect | 90% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 80% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 72% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$25,747
Medicare paid this office $25,747 for 172 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 119 | $14,244 | $69 |
| Short return visit (20+ min) | 58 | $3,341 | $48 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $1,642 | $103 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 19 | $1,261 | $66 |
| Insertion of needle into vein for collection of blood sample | 50 | $606 | $9 |
See all 9 services
| Return visit (30+ min) | 119 | $14,244 | $69 |
| Short return visit (20+ min) | 58 | $3,341 | $48 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $1,642 | $103 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 19 | $1,261 | $66 |
| Insertion of needle into vein for collection of blood sample | 50 | $606 | $9 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 19 | $294 | $15 |
| Injection of drug or substance under skin or into muscle | 16 | $136 | $7 |
| Automated urinalysis test | 24 | $62 | $2 |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $4 | None |
Who their Medicare patients are
172 Original Medicare patients in 2024. Average age 72 · Under 65 14% · 85 and older 13% · Women 66% · Also on Medicaid 20% · Health risk score 1.31. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 31% · Heart failure 31% · Diabetes 28% · Chronic kidney disease 28% · COPD 25% · Depression 22% · Atrial fibrillation 19% · Cancer 11% · Stroke 10% · Dementia 6%.
The office billed $129,269, Medicare allowed $35,007 and paid $25,747; for 621 services of 45 kinds; $924 of it was for drugs given in the office and $24,823 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 172 | 621 | 72 | 1.31 | $129,269 | $25,747 |
| 2023 | 148 | 416 | 72 | 1.22 | $79,074 | $17,320 |
| 2022 | 59 | 166 | 72 | 1.15 | $14,181 | $5,464 |
| 2021 | 39 | 143 | 63 | 1.29 | $14,491 | $4,916 |
| 2020 | 38 | 77 | 59 | 1.14 | $14,477 | $3,058 |
| 2019 | 57 | 172 | 64 | 1.04 | $20,286 | $5,474 |
| 2018 | 57 | 182 | 62 | 1.35 | $11,761 | $4,545 |
| 2017 | 42 | 190 | 63 | 1.48 | $8,491 | $2,777 |
| 2016 | 18 | 63 | 65 | 0.91 | $2,867 | $974 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 68 | $6,099 | $77 |
| Short return visit (20+ min) | 80 | $4,781 | $50 |
| Insertion of needle into vein for collection of blood sample | 31 | $328 | $8 |
| X-ray of chest, 2 views | 12 | $202 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $111 | $9 |
| Automated urinalysis test | 21 | $53 | $2 |
2022: 3 services
| Short return visit (20+ min) | 39 | $3,188 | $47 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 13 | $440 | $34 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $440 | $31 |
2021: 2 services
| Short return visit (20+ min) | 22 | $1,557 | $56 |
| Automated urinalysis test | 17 | $43 | $2 |
2020: 2 services
| Return visit (30+ min) | 12 | $857 | $71 |
| Short return visit (20+ min) | 13 | $658 | $37 |
2019: 4 services
| Short return visit (20+ min) | 27 | $1,498 | $42 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 18 | $633 | $35 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 12 | $383 | $32 |
| Automated urinalysis test | 18 | $46 | $2 |
2018: 7 services
| Short return visit (20+ min) | 18 | $941 | $43 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 14 | $637 | $42 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 13 | $459 | $35 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $430 | $31 |
| Bacterial colony count, urine | 12 | $137 | $10 |
| Automated urinalysis test | 21 | $68 | $3 |
| Insertion of needle into vein for collection of blood sample | 13 | $47 | $3 |
2017: 6 services
| Detection test for candida species (yeast), direct probe technique | 17 | $504 | $27 |
| Detection test for gardnerella vaginalis (bacteria), direct probe technique | 17 | $504 | $27 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique | 17 | $504 | $27 |
| Bacterial colony count, urine | 17 | $315 | $11 |
| Automated urinalysis test | 22 | $121 | $3 |
| Insertion of needle into vein for collection of blood sample | 13 | $41 | $3 |
2016: 1 service
| Automated urinalysis test | 12 | $54 | $3 |
Medicaid work
$11,805 in 2024
Medicaid paid $11,805 for 367 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 203 | $11,805 |
| TOBACCO NON-USER | 164 | $0 |
| 2024 | 367 | 2 | 24 | $11,805 |
| 2023 | 420 | 6 | 27 | $11,986 |
| 2022 | 825 | 6 | 27 | $17,167 |
| 2021 | 994 | 8 | 33 | $6,170 |
| 2020 | 1,675 | 8 | 45 | $3,054 |
| 2019 | 641 | 10 | 38 | $10,114 |
| 2018 | 463 | 7 | 33 | $15,720 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 128 | $7,865 |
| Return visit (30+ min) | 81 | $3,522 |
| URINE PREGNANCY TEST | 56 | $431 |
| HEMOGLOBIN | 62 | $168 |
| Subsequent prenatal care visit (Prenatal) [Excludes: patients who are seen for a condition unrelated to pregnancy or prenatal care (eg, an upper respiratory infection; patients seen for consultation only, not for continuing care)] | 13 | $0 |
| TOBACCO NON-USER | 80 | $0 |
2022
| Short return visit (20+ min) | 253 | $14,950 |
| URINE PREGNANCY TEST | 150 | $1,041 |
| Culture, bacterial; quantitative colony count, urine | 62 | $498 |
| HEMOGLOBIN | 164 | $466 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 80 | $212 |
| Subsequent prenatal care visit (Prenatal) [Excludes: patients who are seen for a condition unrelated to pregnancy or prenatal care (eg, an upper respiratory infection; patients seen for consultation only, not for continuing care)] | 116 | $0 |
2021
| Short return visit (20+ min) | 112 | $5,196 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 248 | $552 |
| URINE PREGNANCY TEST | 44 | $294 |
| Culture, bacterial; quantitative colony count, urine | 12 | $129 |
| Subsequent prenatal care visit (Prenatal) [Excludes: patients who are seen for a condition unrelated to pregnancy or prenatal care (eg, an upper respiratory infection; patients seen for consultation only, not for continuing care)] | 35 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 265 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 214 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 64 | $0 |
2020
| Short return visit (20+ min) | 47 | $1,494 |
| URINE PREGNANCY TEST | 129 | $716 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 286 | $598 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 73 | $171 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 35 | $75 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 549 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 424 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 132 | $0 |
2019
| Short return visit (20+ min) | 149 | $7,680 |
| URINE PREGNANCY TEST | 126 | $811 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 14 | $771 |
| Return visit (30+ min) | 16 | $401 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 141 | $296 |
| HEMOGLOBIN | 34 | $94 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 22 | $59 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 69 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 50 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 20 | $0 |
2018
| Short return visit (20+ min) | 240 | $12,646 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 20 | $1,477 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 13 | $785 |
| URINE PREGNANCY TEST | 62 | $408 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 87 | $231 |
| GLUCOSE POST GLUCOSE DOSE | 27 | $132 |
| HEMOGLOBIN | 14 | $40 |
Drugs they prescribed that Part D paid
$193,788
Pharmacies billed $193,788 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (13 of 2,289) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,957 generic and fewer than 11 brand-name prescriptions · $193,788 in drug cost · 129 antibiotic prescriptions to 108 people · 14 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 46 | $52,691 | $1,145 |
| Trelegy Ellipta | 49 | $32,512 | $664 |
| Eliquis | 23 | $18,839 | $819 |
| Farxiga | 11 | $10,514 | $956 |
| Breztri Aerosphere | 11 | $8,287 | $753 |
See all 65 drugs
| Jardiance | 46 | $52,691 | $1,145 |
| Trelegy Ellipta | 49 | $32,512 | $664 |
| Eliquis | 23 | $18,839 | $819 |
| Farxiga | 11 | $10,514 | $956 |
| Breztri Aerosphere | 11 | $8,287 | $753 |
| Albuterol Sulfate Hfa | 100 | $3,363 | $34 |
| Levetiracetam | 12 | $815 | $68 |
| Fluticasone Propionate | 83 | $781 | $9 |
| Verapamil Er | 11 | $729 | $66 |
| Gabapentin | 59 | $579 | $10 |
| Montelukast | 71 | $456 | $6 |
| Atorvastatin | 68 | $442 | $7 |
| Pantoprazole | 27 | $416 | $15 |
| Bupropion Xl | 25 | $410 | $16 |
| Levothyroxine | 59 | $365 | $6 |
| Losartan | 73 | $350 | $5 |
| Paroxetine | 49 | $342 | $7 |
| Amlodipine Besylate | 96 | $328 | $3 |
| Famotidine | 46 | $325 | $7 |
| Azelastine | 15 | $303 | $20 |
| Rosuvastatin | 47 | $292 | $6 |
| Venlafaxine Hcl Er | 13 | $276 | $21 |
| Diclofenac | 14 | $257 | $18 |
| Buspirone | 18 | $256 | $14 |
| Sertraline | 28 | $255 | $9 |
| Metoprolol | 23 | $244 | $11 |
| Amoxicillin-Clavulanate Potass | 37 | $242 | $7 |
| Omeprazole | 37 | $242 | $7 |
| Esomeprazole Magnesium | 17 | $239 | $14 |
| Pravastatin | 13 | $238 | $18 |
| Valacyclovir | 11 | $237 | $22 |
| Duloxetine | 20 | $224 | $11 |
| Metformin | 36 | $211 | $6 |
| Lisinopril | 49 | $204 | $4 |
| Nitrofurantoin Mono-Macro | 17 | $196 | $12 |
| Levocetirizine Dihydrochloride | 18 | $160 | $9 |
| Nystatin | 14 | $153 | $11 |
| Tizanidine | 19 | $145 | $8 |
| Carvedilol | 21 | $136 | $6 |
| Simvastatin | 15 | $129 | $9 |
| Spironolactone | 13 | $122 | $9 |
| Alendronate | 21 | $109 | $5 |
| Trazodone | 28 | $98 | $3 |
| Citalopram Hbr | 24 | $91 | $4 |
| Hydralazine | 14 | $89 | $6 |
| Topiramate | 11 | $88 | $8 |
| Metoprolol | 18 | $86 | $5 |
| Allopurinol | 11 | $83 | $8 |
| Lisinopril-Hydrochlorothiazide | 11 | $81 | $7 |
| Quetiapine | 17 | $80 | $5 |
| Hydroxyzine Pamoate | 11 | $72 | $7 |
| Fluoxetine | 14 | $69 | $5 |
| Prednisone | 53 | $66 | $1 |
| Metformin Hcl Er | 16 | $63 | $4 |
| Meloxicam | 18 | $63 | $3 |
| Escitalopram | 12 | $62 | $5 |
| Naproxen | 20 | $57 | $3 |
| Amoxicillin | 24 | $55 | $2 |
| Hydrochlorothiazide | 26 | $54 | $2 |
| Fluconazole | 13 | $54 | $4 |
| Cephalexin | 17 | $53 | $3 |
| Doxycycline Hyclate | 13 | $48 | $4 |
| Furosemide | 16 | $47 | $3 |
| Tamsulosin | 12 | $40 | $3 |
| Tramadol | 13 | $36 | $3 |
Year by year
| 2024 | 2,289 | 342 | 1% (13) | None | $193,788 |
| 2023 | 728 | 235 | None | None | $47,305 |
| 2022 | 169 | 78 | 0% (0) | 16% | $10,005 |
| 2021 | 70 | 46 | 0% (0) | None | $3,948 |
| 2020 | 58 | 32 | 0% (0) | None | $2,047 |
| 2019 | 153 | 66 | 0% (0) | 15% | $10,901 |
| 2018 | 165 | 59 | 0% (0) | 10% | $8,988 |
| 2017 | 184 | 61 | 0% (0) | 21% | $12,268 |
| 2016 | 170 | 76 | 0% (0) | 18% | $10,284 |
| 2015 | 159 | 68 | 0% (0) | None | $8,079 |
| 2014 | 18 | 13 | 0% (0) | None | $742 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Estradiol | 47 | $4,085 | $87 |
| Albuterol Sulfate Hfa | 18 | $441 | $24 |
| Fluticasone Propionate | 35 | $438 | $13 |
| Valacyclovir | 12 | $407 | $34 |
| Diclofenac | 12 | $305 | $25 |
| Nystatin | 13 | $165 | $13 |
| Gabapentin | 17 | $152 | $9 |
| Montelukast | 19 | $150 | $8 |
| Amoxicillin-Clavulanate Potass | 20 | $146 | $7 |
| Amlodipine Besylate | 13 | $103 | $8 |
| Buspirone | 12 | $95 | $8 |
| Fluconazole | 13 | $74 | $6 |
| Azithromycin | 14 | $66 | $5 |
| Lisinopril | 14 | $65 | $5 |
| Cephalexin | 16 | $65 | $4 |
| Sronyx | 13 | $59 | $5 |
| Naproxen | 16 | $53 | $3 |
| Omeprazole | 11 | $48 | $4 |
| Sulfamethoxazole-Trimethoprim | 12 | $46 | $4 |
| Prednisone | 18 | $32 | $2 |
2022: 4 drugs
| Estradiol | 38 | $2,645 | $70 |
| Medroxyprogesterone Acetate | 17 | $554 | $33 |
| Nitrofurantoin Mono-Macro | 12 | $203 | $17 |
| Fluconazole | 11 | $30 | $3 |
2019: 4 drugs
| Estradiol | 21 | $2,065 | $98 |
| Metronidazole | 16 | $1,100 | $69 |
| Junel | 11 | $199 | $18 |
| Fluconazole | 13 | $64 | $5 |
2018: 6 drugs
| Metronidazole | 23 | $1,262 | $55 |
| Estradiol | 12 | $929 | $77 |
| Junel | 18 | $349 | $19 |
| Paroxetine | 14 | $158 | $11 |
| Valacyclovir | 11 | $150 | $14 |
| Fluconazole | 12 | $61 | $5 |
2017: 7 drugs
| Estrace | 14 | $4,049 | $289 |
| Premarin | 11 | $3,825 | $348 |
| Metronidazole | 25 | $1,678 | $67 |
| Junel | 12 | $170 | $14 |
| Estradiol | 13 | $168 | $13 |
| Valacyclovir | 11 | $147 | $13 |
| Fluconazole | 11 | $57 | $5 |
2016: 5 drugs
| Estrace | 12 | $3,186 | $265 |
| Clobetasol Propionate | 11 | $1,367 | $124 |
| Metronidazole | 14 | $887 | $63 |
| Estradiol | 16 | $487 | $30 |
| Fluconazole | 13 | $65 | $5 |
2015: 2 drugs
| Metronidazole | 36 | $1,502 | $42 |
| Valacyclovir | 14 | $417 | $30 |
Money from drug and device companies
$684 in 2025
| 2025 | 16 | 39 | None | $684 |
| 2024 | 11 | 24 | None | $449 |
| 2023 | 8 | 11 | None | $187 |
| 2022 | 6 | 8 | None | $227 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $192 | 15 payments
|
| Novo Nordisk | Rybelsus | $85 | 4 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $84 | 4 payments
|
| Vanda Pharmaceuticals | Fanapt | $50 | 2 payments
|
| ACADIA Pharmaceuticals | Daybue | $37 | 2 payments
|
| Lilly USA | Jardiance | $34 | 1 payment
|
See all 39 published payments
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-21 | Xifaxan | $22 |
| ACADIA Pharmaceuticals | Meals · 2025-12-19 | Daybue | $17 |
| Abbvie | Meals · 2025-12-09 | Vraylar | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-09 | Caplyta | $21 |
| Abbvie | Meals · 2025-11-13 | Vraylar | $7 |
| Ascensia Diabetes Care Us | Meals · 2025-11-10 | None | $15 |
| Abbvie | Meals · 2025-10-15 | Qulipta | $23 |
| GlaxoSmithKline | Meals · 2025-10-10 | Trelegy Ellipta | $17 |
| Abbvie | Meals · 2025-10-02 | Vraylar | $7 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-30 | Caplyta | $23 |
| Abbvie | Meals · 2025-09-10 | Qulipta | $16 |
| Abbvie | Meals · 2025-09-03 | Vraylar | $11 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-22 | Airsupra | $15 |
| Abbvie | Meals · 2025-08-18 | Qulipta | $29 |
| Abbvie | Meals · 2025-08-06 | Vraylar | $7 |
| Axsome Therapeutics | Meals · 2025-07-30 | Auvelity | $26 |
| Novo Nordisk | Meals · 2025-07-22 | Rybelsus | $18 |
| ACADIA Pharmaceuticals | Meals · 2025-07-14 | Daybue | $20 |
| Vanda Pharmaceuticals | Meals · 2025-07-10 | Fanapt | $29 |
| Abbvie | Meals · 2025-07-09 | Vraylar | $8 |
| Novo Nordisk | Meals · 2025-06-11 | Rybelsus | $23 |
| Abbvie | Meals · 2025-06-11 | Vraylar | $7 |
| Abbvie | Meals · 2025-05-16 | Ubrelvy | $33 |
| Abbvie | Meals · 2025-05-14 | Vraylar | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-28 | Caplyta | $19 |
| Vanda Pharmaceuticals | Meals · 2025-04-24 | Fanapt | $21 |
| Abbvie | Meals · 2025-04-16 | Vraylar | $7 |
| Exact Sciences | Meals · 2025-04-10 | Cologuard Collection Kit | $20 |
| Lilly USA | Meals · 2025-04-02 | Jardiance | $34 |
| Astellas Pharma US | Meals · 2025-03-27 | Veozah | $22 |
| Novo Nordisk | Meals · 2025-03-12 | Wegovy | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-12 | Caplyta | $21 |
| Abbvie | Meals · 2025-02-19 | Vraylar | $8 |
| Pfizer | Meals · 2025-02-07 | Eliquis | $20 |
| Phathom Pharmaceuticals | Meals · 2025-02-04 | Voquezna | $18 |
| Amgen | Meals · 2025-01-28 | Repatha | $14 |
| GlaxoSmithKline | Meals · 2025-01-22 | Trelegy Ellipta | $14 |
| Abbvie | Meals · 2025-01-15 | Vraylar | $9 |
| Novo Nordisk | Meals · 2025-01-14 | Ozempic | $23 |
See earlier years (2024, 2023, 2022)
2024: $449
| Abbvie | Vraylar | $92 | 4 payments
|
| Exact Sciences | Cologuard Collection Kit | $69 | 4 payments
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $52 | 3 payments
|
| Amgen | Repatha | $50 | 3 payments
|
| Novo Nordisk | Ozempic | $33 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $32 | 2 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $31 | 2 payments
|
| Lilly USA | Mounjaro | $29 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $23 | 1 payment
|
| GlaxoSmithKline | Arexvy | $23 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $15 | 1 payment
|
2023: $187
| Novo Nordisk | Rybelsus | $42 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Mirena | $35 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $27 | 2 payments
|
| Abbvie | Vraylar | $17 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $17 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $17 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $16 | 1 payment
|
| Lilly USA | Mounjaro | $14 | 1 payment
|
2022: $227
| Aspira Women's Health | Ova1 | $109 | 1 payment
|
| Abbvie | Lo Loestrin Fe | $56 | 3 payments
|
| Mayne Pharma | None | $18 | 1 payment
|
| Boston Scientific | Solyx Sis System | $17 | 1 payment
|
| Davol | Arista Ah Flexitip | $15 | 1 payment
|
| Baxter Healthcare | Seprafilm | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780098046
- Licence
- GA RN186285
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LW0102X (363LW0102X)
- Mailing address
- Po Box 12938, C/O Clinic Management, Calhoun, GA, 30703
- NPI first listed
- 2014-06-16
- NPI last updated
- 2026-03-23
- NPI record certified
- 2026-03-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 165 Broadway Fl 23, New York, NY, 10006 · 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306